Detalles de la búsqueda
1.
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer.
Cancer
; 126(13): 3132-3139, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32286687
2.
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients.
Int J Gynecol Cancer
; 29(2): 325-333, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30700568
3.
Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates.
J Immunother Cancer
; 9(9)2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34531249
4.
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
J Clin Oncol
; 35(35): 3942-3948, 2017 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29072977
Resultados
1 -
4
de 4
1
Próxima >
>>